Ownership
Private
Therapeutic Areas
Other
Stage
Other
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Modalities
mRNA-based drugsOligonucleotidesLarge molecules (including proteins and biologics)

SoCal Biosciences General Information

SoCal Biosciences is an active, woman-owned bioanalytical contract research organization specializing in assay development and analytical support for mRNA, oligonucleotide, and large molecule therapeutics. The company offers end-to-end services including new drug candidate screening, biodistribution studies for RNA platforms, pharmacokinetic/pharmacodynamic analysis, immunogenicity testing, and biomarker assays. Founded by Dr. Patty Limphong in 2022 in San Diego, it emphasizes quality data delivery with expertise in RNA-based therapeutics.

Contact Information

Primary Industry
Contract Research Organization
Corporate Office
San Diego, California
United States

Drug Pipeline

No pipeline data available

For full access to SoCal Biosciences's pipeline data

Book a demo

Key Partnerships

No major pharmaceutical or biotech partnerships publicly listed as of June 2025.

Need more data on over 80,000 life science companies, including over 1200 biotechs?

Book a demo

SoCal Biosciences Funding

No funding data available

Early Stage VC (Series A)04-Jun-2020$38MCompletedPhase 1
Seed Round12-Feb-2019$8.5MCompletedStartup

Interested in comprehensive profile data?

We'll help you find what you need

Learn more
To view SoCal Biosciences's complete valuation and funding history, request access »

SoCal Biosciences Financial Metrics